FindTrial
Sign In

Bronchiectasis registry across India

Indian National Bronchiectasis Audit and Research Collaboration Registry - INBARC Registry

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/07/113599
Enrollment
300
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

European Respiratory Society
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. more than equal to 18 yrs 2.willing to give informed consent 3.Clinical syndrome consistent with bronchiectasis like chronic sputum production and or recurrent lower respiratory tract infections 4.HRCT chest demonstrating bronchiectasis 5. No acute exacerbation in the preceding 4 weeks

Exclusion criteria

Exclusion criteria: 1.Active pulmonary tuberculosis 2.Known HIV infection 3.Use of daily systemic corticosteroids more than equal 10 mg within the past 4 wks 4.Use of systemic antibiotics for a pulmonary exacerbation within the preceding 4 weeks.

Design outcomes

Primary

MeasureTime frame
etiology and characteristics of bronchiectasis in Indian contextTimepoint: At baseline,6 month, 12 month and 24 month—

Secondary

MeasureTime frame
To see spirometric and oscillometric parameters and also the result of exhaled nitric oxide estimationTimepoint: 3 yrs—

Countries

India

Contacts

Public ContactDr Raja Dhar

The Calcutta Medical Research Institute

pulmoresearch@gmail.com9831855512

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026